Editas Medicine to Present New Data Demonstrating Advancements for Translating CRISPR Technologies into Medicines at the American ...
Oral presentation of first achievement of in vivo retinal gene editing in non-human primates Oral presentation of results demonstrating the potential of CRISPR/Cas9 gene editing to treat sickle cell disease and beta-thalassemia CAMBRIDGE, Mass., April 24, …